Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Urtica dioica (root)
Stinging nettle root is a distinct medicinal preparation from nettle leaf, with different active compounds and therapeutic applications. While the leaf is used primarily for allergies and nutrition, the root is specifically studied for prostate health and urinary symptoms. It is approved by the German Commission E for BPH.
Stinging nettle root (Urtica dioica) is a distinct medicinal preparation from the leaf, approved by the German Commission E for benign prostatic hyperplasia (BPH). Its primary uses include improving lower urinary tract symptoms and supporting prostate health, with key active compounds such as beta-sitosterol, lignans, and lectins (UDA) contributing to its anti-inflammatory and anti-proliferative effects.
Stinging nettle root exerts its effects through multiple mechanisms: beta-sitosterol and lignans inhibit 5-alpha-reductase, reducing conversion of testosterone to dihydrotestosterone (DHT), while lectins (UDA) modulate sex hormone-binding globulin (SHBG) binding. Additionally, polysaccharides and scopoletin exhibit anti-inflammatory activity by inhibiting cyclooxygenase (COX) and lipoxygenase (LOX) pathways, and may suppress prostate cell proliferation via growth factor modulation.
Stinging nettle root is a distinct medicinal preparation from nettle leaf, with different active compounds and therapeutic applications. While the leaf is used primarily for allergies and nutrition, the root is specifically studied for prostate health and urinary symptoms. It is approved by the German Commission E for BPH.
Stinging nettle root (Urtica dioica) is a distinct medicinal preparation from the leaf, approved by the German Commission E for benign prostatic hyperplasia (BPH). Its primary uses include improving lower urinary tract symptoms and supporting prostate health, with key active compounds such as beta-sitosterol, lignans, and lectins (UDA) contributing to its anti-inflammatory and anti-proliferative effects.
Stinging nettle root exerts its effects through multiple mechanisms: beta-sitosterol and lignans inhibit 5-alpha-reductase, reducing conversion of testosterone to dihydrotestosterone (DHT), while lectins (UDA) modulate sex hormone-binding globulin (SHBG) binding. Additionally, polysaccharides and scopoletin exhibit anti-inflammatory activity by inhibiting cyclooxygenase (COX) and lipoxygenase (LOX) pathways, and may suppress prostate cell proliferation via growth factor modulation.